Abbott Laboratories vs Medline
Abbott Laboratories (ABT) and Medline (MDLN) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $178B
- Last close
- $103.00
- 12 months
- −16.9%
- Market value
- $48.7B
- Last close
- $37.04
- 12 months
- —
At a glance
- The biggest part of Abbott Laboratories's revenue is Medical Devices (48%); at Medline it is Supply Chain Solutions (52%).
- Abbott Laboratories earns 39% of its revenue in the United States, Medline 93%.
- By market value, Abbott Laboratories ($178.4B) is about 3.7 times Medline ($48.7B).
- In their last fiscal years Abbott Laboratories kept 14.7% of revenue as net income and Medline 4.1%.
- In the last 90 days insiders reported 0 open-market purchases at Abbott Laboratories and 0 at Medline; members of Congress disclosed 3 trades in Abbott Laboratories and 0 in Medline.
- Next results: Abbott Laboratories Jan 20, 2027, Medline Feb 23, 2027.
How each one makes money: Abbott Laboratories revenue · Medline revenue
Share prices on one chart
Abbott Laboratories and Medline, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Abbott Laboratories ABTNYSE · Health Care Equipment | Medline MDLNNASDAQ · Surgical & Medical Instruments & Apparatus | |
|---|---|---|
| Size and profitability | ||
| Market value | $178B | $48.7B |
| Revenue, last fiscal year | $44.3B | $28.4B |
| Net income, last fiscal year | $6.52B | $1.16B |
| Net marginNet income as a share of revenue | 14.7% | 4.1% |
| Free cash flow | $7.39B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Abbott Laboratories against
Common questions
How is Abbott Laboratories different from Medline?
Abbott Laboratories (ABT) is in Health Care Equipment on NYSE, with $44.3B of revenue in its last fiscal year and a net margin of 14.7%. Medline (MDLN) is in Surgical & Medical Instruments & Apparatus on NASDAQ, with $28.4B of revenue in its last fiscal year and a net margin of 4.1%. The biggest part of Abbott Laboratories's revenue is Medical Devices (48%); at Medline it is Supply Chain Solutions (52%). Abbott Laboratories earns 39% of its revenue in the United States, Medline 93%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Abbott Laboratories and Medline compare in size?
Abbott Laboratories has the larger market value: Abbott Laboratories $178B and Medline $48.7B, at the last close.
Whose share price rose more over the last 12 months, ABT or MDLN?
A 12-month price change is not available for both companies.
Which has had more insider buying, Abbott Laboratories or Medline?
Since 2006, Abbott Laboratories insiders reported 377 open-market purchases against 0 for Medline. These are counts of what was filed, not a view on either stock.
Do members of Congress trade ABT or MDLN?
In the last 12 months, members of Congress disclosed 28 trades in Abbott Laboratories (ABT) and 0 in Medline (MDLN).
When did insiders last buy ABT and MDLN?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Abbott Laboratories pageMedline pageRare insider trades this weekAll comparisons
https://oqro.io/compare/abt-vs-mdln







